Cite
HARVARD Citation
Fennell, D. et al. (n.d.). Niraparib efficacy in patients with unresectable mesothelioma: a randomised phase II trial of niraparib versus active symptom control in patients with previously treated mesothelioma: NERO (TRIALS IN PROGRESS). Lung cancer. pp. S85-S86. [Online].